Nightingale Technology
Nightingale Technology is a healthcare software company that has developed a patient 'superchart'—a high fidelity, comprehensive patient data record designed to improve healthcare delivery by providing a more complete and readable patient chart for providers and staff. Emerging from stealth in 2024 after three years of R&D, Nightingale focuses initially on senior care physician organizations in the U.S., particularly those operating under Medicare total-cost-of-care risk models. Their platform aggregates and normalizes patient data across multiple providers, suppliers, and insurers to enable advanced intelligence use cases that augment care delivery and close blind spots. The company aligns its business model with healthcare outcomes by partnering with physician networks under capitation payment models, incentivizing high-quality preventive care and disease management. Nightingale is currently in private preview with plans to expand access in early 2025. The company emphasizes EMR agnosticism, human-in-the-loop review for AI outputs, and aims for 10x improvements over existing solutions.
Nightingale Technology
Nightingale Technology is a healthcare software company that has developed a patient 'superchart'—a high fidelity, comprehensive patient data record designed to improve healthcare delivery by providing a more complete and readable patient chart for providers and staff. Emerging from stealth in 2024 after three years of R&D, Nightingale focuses initially on senior care physician organizations in the U.S., particularly those operating under Medicare total-cost-of-care risk models. Their platform aggregates and normalizes patient data across multiple providers, suppliers, and insurers to enable advanced intelligence use cases that augment care delivery and close blind spots. The company aligns its business model with healthcare outcomes by partnering with physician networks under capitation payment models, incentivizing high-quality preventive care and disease management. Nightingale is currently in private preview with plans to expand access in early 2025. The company emphasizes EMR agnosticism, human-in-the-loop review for AI outputs, and aims for 10x improvements over existing solutions.